AzTrials
AzTrials

Mobile ApplicationNCT06168656

Examining a Mobile App's Impact on Expectant Fathers' Fear of Childbirth and Paternal Attachment

A study testing Mobile Application in people with Mobile Application and Expectant Fathers, run by Pamukkale University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Historically, reproduction and childbirth have conventionally been seen solely as a transition into motherhood and as matters primarily concerning the women. Expectant fathers often experience fear and stress in the perinatal period. Gender roles dictate that men should exude strength and self-assuredness. Read more about this study

Who is it for?
Ages 18 to 65 years, men only
What is being tested?
Mobile Application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
No sites listed yet
Study dates
31 Dec 2023to 30 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 and above,
  • Users of smartphones and social media,
  • Willing to participate in the research,
  • Proficient in understanding, speaking, and writing in Turkish,
  • At least completed primary education,
  • First-time fathers,
Show all 9Show fewer
  • Have not attended any antenatal education program,
  • Have internet access and have used any mobile application before,
  • Spouses with low-risk pregnancies in the 20-28 weeks gestational age and without a cesarean indication will be eligible for participation.

Who cannot join

  • Fathers who have previously experienced childbirth before the post-test.
  • Fathers who wish to withdraw from the research.
  • Fathers who do not complete the educational program will be excluded from the study.

Trial locations and contacts

No sites are listed yet.

Büşra Değirmenciler, MSc contact

05385476202

bdegirmenciler@pau.edu.tr

About this study

Official title: Investigating the Effects of Mobile Application for Expectant Fathers About Preparation for Birth and Parenthood on Fear of Childbirth and Paternal Attachment

Historically, reproduction and childbirth have conventionally been seen solely as a transition into motherhood and as matters primarily concerning the women. Expectant fathers often experience fear and stress in the perinatal period. Gender roles dictate that men should exude strength and self-assuredness. Hence, it leads expectant fathers to withhold their fears and emotions. Expectant fathers seek specific information about the process and may struggle with emotional expression. Fathers who overlook their own needs are unable to provide adequate support to their partners. Consequently, expectant mothers are more prone to experiencing heightened levels of stress, anxiety, and depression, and they may lean towards opting for cesarean deliveries. Additionally, they might persist in engaging in risky behaviors, such as smoking, and face challenges in maintaining breastfeeding. Support provided to expectant fathers leads to a positive influence on the health of both mothers and newborns. The development of technology has led to significant increase in the utilization of mobile devices within the healthcare. The implementation of mobile device interventions does not increase the workload on institutions and healthcare professionals. Hence, it can be utilized to address the needs of expectant fathers. For this reason, the aim of this study is to develop a mobile application to reduce expectant fathers' fear of childbirth and enhance paternal attachment.

Read the detailed description

This study was planned as a parallel, single-blind, pre-post-test randomized controlled experimental study in which two groups (experiment-control) will be compared. The block randomization method will be used. The expectant fathers who will participate in the research will be reached through social media networks related to parenthood (Facebook and Instagram accounts) and the data will be collected from expectant fathers who are suitable for the sample characteristics through mobile application. The sample size was calculated in the G*power statistics program by utilizing the data of a study in which on expectant parents using a mobile application intervention was previously performed (α =0.05, d=0.80). Accordingly, it was found that 16 expectant fathers should be taken for each group to sampling for 80% power. Considering that there might be losses, the number of samples was increased by 40% and it was planned to include a total of 54 expectant fathers in the study. Intention-to-treat analysis will be performed to manage bias and losses. A pilot application will be conducted for 4 weeks with 6 expectant fathers regarding the usability of the mobile application and these expectant fathers will not be included in the study. At the end of 4 weeks, feedback will be received from the expectant fathers participating in the pilot application with the mobile application evaluation form. Necessary changes will be made in the mobile application in line with the feedback.

Being tested
Mobile Application
Keywords
Mobile application, Antenatal Education, Fatherhood, Mobile Health

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile ApplicationBehavioural

    The mobile application will include the following features:

    Direct Message Section: This section will allow expectant fathers to ask specialized questions directly to experts or specialists.

    Forum Section: Expectant fathers can use this section to engage in discussions and connect with each other.

    Education Section: This section is specifically designed to cater to the educational needs of expectant fathers.

Study groups in NCT06168656
Study groupRoleWhat they receive
ExperimentalExperimentalThe experimental group will use a mobile application intervention developed for expectant fathers.
Receives: Behavioral: Mobile Application
No InterventionNo interventionControl group receive routine care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fear of Birth Scale (FOBS)

    This scale was developed by Haines et al. in 2011 to measure the fear of childbirth. In the scale, the participants were asked to rate their feelings by marking the statements (a) 'calm/worried' (b) 'no fear/strong fear' on two 100 mm lines to answer the question "How do you feel right now about the approaching birth?". Cronbach's Alpha internal consistency coefficient of the scale was 0.91. The cut-off score of the scale was 50. Participants who obtained a score of 50 or above were considered to fear of childbirth.

    Measured: Baseline and 6 weeks after

  2. Paternal Antenatal Attachment Scale-PAAS

    The PAAS was developed by Condon in 1993. The scale comprises 16 items. Each item of the scale focuses on measuring the father's emotions, attitudes, behaviors, and thoughts toward the developing fetus during pregnancy, with most items based on fathers' experiences in the last two weeks. Items are rated on a five-point Likert scale ranging from 1 to 5, with a total score range of 16-80. Lower scores indicate less antenatal attachment.

    Measured: Baseline and 6 weeks after

  3. Introductory Information Form

    This form includes sociodemographic questions such as age, gestational week, education level, employment status, and economic situation.

    Measured: Baseline

  4. Mobile Application Evaluation Form

    This researcher-designed form assesses user satisfaction with the mobile app, gathering feedback on usability and content following the pilot application.

    Measured: 4 weeks after the pilot intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2023
  2. Study start31 Dec 2023 (estimated)
  3. Primary completion30 Mar 2024 (estimated)
  4. Study completion30 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single blind pre-post test randomized controlled design
Masking
Single blind
Who is masked
Participant
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06168656
Sponsor's protocol ID
E-60116787-020-301336
Status last verified
Dec 2023
First submitted
5 Dec 2023
Last updated
13 Dec 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Mobile Application in people with Mobile Application and Expectant Fathers, run by Pamukkale University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Büşra Değirmenciler, MSc (05385476202, bdegirmenciler@pau.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fear of Birth Scale (FOBS) (time frame: Baseline and 6 weeks after). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in